IDP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biogen Inc

Watchlist Manager

Watchlist

Price: 173.8 EUR -1.34% Market Closed

Market Cap: €25.3B

B	Biogen Inc DUS:IDP	US
B	Bank Central Asia Tbk PT XMUN:BZG2	ID
	Sun Pharmaceutical Industries Ltd BSE:524715	IN
	Akron PAO MOEX:AKRN	RU
B	Barclays PLC XMUN:BCY	UK

Profitability Summary

Biogen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

76%

Declining Gross Margin

77% > 75%

Healthy Operating Margin

26%

Sustainable 3Y Average Operating Margin

26%

Declining Operating Margin

30% > 26%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

15%

Declining Net Margin

27% > 14%

Exceptional Free Cash Flow Margin

24%

Strong 3Y Average Free Cash Flow Margin

18%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.